Intracutaneous injection of the macrophage-activating lipopeptide-2 (MALP-2) which accelerates wound healing in mice - A phase I trial in 12 patients

Experimental Dermatology

Volumn 17, Issue 12, 2008, Pages 1052-1056

  Niebuhr, Margarete ^a   Mühlradt, Peter F ^b   Wittmann, Miriam ^a   Kapp, Alexander ^a   Werfel, Thomas ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Wound Healing Research Group   (Germany)

Author keywords

Diabetes mellitus; Human; Intracutaneous injection; Macrophage activating lipopeptide 2 (MALP 2); Wound healing

Indexed keywords

MACROPHAGE ACTIVATING LIPOPEPTIDE 2; PLACEBO;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; FEMALE; FEVER; HEAT SENSATION; HUMAN; HUMAN TISSUE; INJECTION SITE BLEEDING; MALE; MOUSE; NONHUMAN; PHASE 1 CLINICAL TRIAL; PRURITUS; SIDE EFFECT; SKIN BIOPSY; SKIN INFLAMMATION; SKIN INJURY; SKIN PAIN; WOUND DRESSING; WOUND HEALING;

AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD31; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CHEMOKINE CCL2; COLLAGEN TYPE IV; ERYTHEMA; FEMALE; HUMANS; INJECTIONS, INTRADERMAL; LIPOPEPTIDES; MALE; MIDDLE AGED; MONOCYTES; TREATMENT OUTCOME; WOUND HEALING; WOUNDS AND INJURIES;

EID: 56349127390     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2008.00750.x     Document Type: Article

References (19)

1. Shpacovitch V M, Seeliger S, Huber-Lang M et al. Agonists of proteinase-activated receptor-affect transendothelial migration and apoptosis of human neutrophils. Exp Dermatol 2007: 16: 799-806.
2. Ohtani T, Mizuashi M, Ito Y, Aiba S. Cadexomer as well as cadexomer iodine induces the production of proinflammatory cytokines and vascular endothelial growth factor by human macrophages. Exp Dermatol 2007: 16: 318-323.
3. Artuc M, Hermes B, Algermissen B, Henz B M. Expression of prothrombin, thrombin and its receptors in human scars. Exp Dermatol 2006: 15: 523-529.
4. Deiters U, Barsig J, Tawil B, Mühlradt P F. The macrophage-activating lipopeptide-2 accelerates wound healing in diabetic mice. Exp Dermatol 2004: 13: 731-739.
5. Laato M, Lehtonen O P, Niinikoski J. Granulation tissue formation in experimental wounds inoculated with Staphylococcus aureus. Acta Chir Scand 1985: 151: 313-318.
6. Leibovich S J, Ross R. The role of macrophages in wound repair. A study with hydrocortisone and macrophage serum. Am J Pathol 1975: 78: 71-100.
7. Pierce G F, Tarpley J E, Tseng J et al. Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds. J Clin Invest 1995: 96: 1336-1350.
8. Okumura M, Okuda T, Nakamura T, Yajima M. Acceleration of wound healing in diabetic mice by basic fibroblast growth factor. Biol Pharm Bull 1996: 19: 530-535.
9. Wu L, Yu Y L, Galiano R D, Roth S I, Mustoe T A. Macrophage colony-stimulating factor accelerates wound healing and upregulates TGF-beta1 mRNA levels through tissue macrophages. J Surg Res 1997: 72: 162-169.
10. O'Kane S, Ferguson M W. Transforming growth factor beta and wound healing. Int J Biochem Cell Biol 1997: 29: 63-78.
11. Jaschke E, Zabernigg A, Gattringer C. Recombinant human granulocyte-macrophage colony stimulating factor applied locally in low doses enhances healing and prevents recurrence of chronic venous ulcers. Int J Dermatol 1999: 38: 380-386.
12. Koveker G B. Growth factors in clinical practise. Int J Clin Pract 2000: 54: 590-593.
13. Hom D B, Thatcher G, Tibesar R. Growth factor therapy to improve soft tissue healing. Facial Plast Surg 2002: 18: 41-52.
14. Mühlradt P F, Kieß M, Meyer H, Süßmuth R, Jung G. Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at pico molar concentration. J Exp Med 1997: 185: 1951-1958.
15. Deiters U, Gumenscheimer M, Galanos C, Mühlradt P F. Toll-like receptor 2- and 6-mediated stimulation by macrophage-activating lipopeptide 2 induces lipopolysaccharide (LPS) cross tolerance in mice, which results in protection from tumor necrosis factor alpha but in only partial protection from lethal LPS doses. Infect Immun 2003: 71: 4456-4462.
16. Morr M, Takeuchi O, Akira S, Simon M M, Mühlradt P F. Differential recognition of structural details of bacterial lipopeptides by toll-like receptors. Eur J Immunol 2002: 32: 3337-3347.
17. Portera C A, Love E J, Memore L et al. Effect of macrophage stimulation on collagen biosynthesis in the healing wound. Am Surg 1997: 63: 125-131.
18. Qiu J G, Chang T H, Steinberg J J, Levenson S M. Single local instillation of Staphylococcus aureus peptidoglycan prevents diabetes-induced impaired wound healing. Wound Repair Regen 1998: 6: 449-456.
19. Leibovich S J, Danon D. Promotion of wound repair in mice by application of glucan. J Reticuloendothel Soc 1980: 27: 1-11.